首页> 外国专利> USE OF SMALL MOLECULE COMPOUNDS IN TREATING DISEASES MEDIATED BY LUNG EPITHELIAL CELL INJURY AND/OR VASCULAR ENDOTHELIAL CELL INJURY

USE OF SMALL MOLECULE COMPOUNDS IN TREATING DISEASES MEDIATED BY LUNG EPITHELIAL CELL INJURY AND/OR VASCULAR ENDOTHELIAL CELL INJURY

机译:使用小分子化合物治疗肺上皮细胞损伤和/或血管内皮细胞损伤介导的疾病

摘要

Applications of 5α-androst-3β,5,6β-triol and an analog thereof, a deuterated compound thereof, or a pharmaceutically acceptable salt thereof in preparing a drug for treating a pulmonary disease of a patient. These compounds can remarkably inhibit up-regulated expression of PFKFB3, remarkably inhibit accumulation of lactic acid, remarkably reduce vascular endothelial cell injury, remarkably reduce alveolar epithelial cell injury, remarkably inhibit thickening of an alveolar septum, and remarkably reduce alveolar injury, so that these compounds can be used for treating pulmonary diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury.
机译:5α-androst-3β,5,6β-triol及其类似物,其氘代化合物或其药学上可接受的盐在制备用于治疗患者的肺病中的药学上可接受的盐。 这些化合物可以显着抑制pFKFB3的上调表达,显着抑制乳酸的积累,显着降低血管内皮细胞损伤,显着降低肺泡上皮细胞损伤,显着抑制肺泡隔膜的增厚,并且显着降低肺泡损伤,因此这些 化合物可用于治疗由肺上皮细胞损伤和/或血管内皮细胞损伤介导的肺部疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号